Diabetic Foot Ulcer Treatment Market Analysis

  • Report ID: 4603
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Diabetic Foot Ulcer Treatment Market Segmentation:

Ulcer Type 

The global diabetic foot ulcer treatment market is segmented and analyzed for demand and supply by ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.

End-user 

The global diabetic foot ulcer treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and homecare. Amongst these four segments, the hospital segment is expected to garner a significant share. The patient suffering with diabetic ulcers should be taken to hospitals, as ulcers can lead to severe infection and it can increase the risk of amputation. Therefore, to avoid the stage of amputation, the patient should be given immediate care of the hospital for dealing with complicated ulcers. The properly trained staff of the hospital can provide intensive care and the patient can be treated with multiple services present in the hospital.

Our in-depth analysis of the global market includes the following segments:

By Ulcer Type

  • Neuropathic Ulcer
  • Ischemic Ulcer
  • Neuro-Ischemic Ulcer

By Product

  • Wound-Care Dressings
  • Wound-Care Devices
  • Active Therapies
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of diabetic foot ulcer treatment is assessed at USD 7.3 billion.

The global diabetic foot ulcer treatment market size was valued at over USD 6.92 billion in 2025 and is expected to expand at a CAGR of around 6.1%, surpassing USD 12.51 billion revenue by 2035.

North America diabetic foot ulcer treatment market will hold over 38.8% share by 2035, driven by rising peripheral neuropathy cases among diabetics and increasing treatment options for ulcer diagnosis.

Key players in the market include UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos